Mark Sye is an experienced quality assurance professional with a career spanning over two decades in the biotechnology and pharmaceutical industries. Currently serving as the Director of Quality Assurance at uBriGene Biosciences Inc. since November 2024, Mark previously held the position of Sr. Manager, Quality System at Catalent Cell and Gene Therapy from September 2022 to September 2024. Earlier roles include Associate Director and Manager of Quality Assurance Compliance at MacroGenics, Inc., as well as Supervisor positions at GSK US and Baxter International Inc. Mark began a career in quality assurance at BD as a Group Lead. Mark holds a degree in Medical Technology from Morgan State University, obtained in 1997.
This person is not in the org chart
This person is not in any teams
This person is not in any offices